Peak Bio, Inc.
PKBO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $368 | $0 | $528 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $368 | $608 | $528 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $0 | $1,627 | $0 | $7,124 |
| G&A Expenses | $0 | $0 | $8,531 | $2,470 |
| SG&A Expenses | $2 | $1 | $8,531 | $2,470 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$819 | $0 |
| Operating Expenses | $2 | $1 | $1 | $9,594 |
| Operating Income | -$2 | -$1 | -$1 | -$9,066 |
| % Margin | – | -0.4% | – | -1,716% |
| Other Income/Exp. Net | -$0 | $240 | -$0 | $855 |
| Pre-Tax Income | -$2 | -$1 | -$1 | -$8,211 |
| Tax Expense | $0 | $0 | -$74 | $82 |
| Net Income | -$2 | -$1 | -$1 | -$8,293 |
| % Margin | – | -0.3% | – | -1,569.7% |
| EPS | -0.019 | -0 | -0.74 | -0.48 |
| % Growth | -44,944.9% | 100% | -54.2% | – |
| EPS Diluted | -0.021 | -0 | -0.74 | -0.48 |
| Weighted Avg Shares Out | 80 | 29,543 | 17,712 | 20,058 |
| Weighted Avg Shares Out Dil | 87 | 29,543 | 17,712 | 20,058 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2 | $0 |
| Interest Expense | $0 | $0 | $48 | $11 |
| Depreciation & Amortization | $0 | $0 | $786 | $177 |
| EBITDA | -$2 | -$1 | -$12,328 | -$8,022 |
| % Margin | – | -0.4% | – | -1,518.4% |